Market Cap

Harrow Health, Inc. Market Capitalization:

$1.85 Billion

USD as of Jan. 1, 2026

business Harrow Health, Inc. Company Profile

Harrow Health, Inc. Main Stock Listing

NASDAQ: HROW

Market Capitalization History of Harrow Health, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
MERCK Kommanditgesellschaft auf Aktien $62.01 B
Zoetis Inc. $55.81 B
Takeda Pharmaceutical Company Limited $45.42 B
Haleon plc $44.50 B
Teva Pharmaceutical Industries Limited $35.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Harrow Health, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.85 B 55.54%
Jan. 1, 2025 $1.19 B 221.08%
Jan. 1, 2024 $370.1 M -11.12%
Jan. 1, 2023 $416.5 M 86.80%
Jan. 1, 2022 $222.9 M -16.67%
Jan. 1, 2021 $267.5 M 54.64%
Jan. 1, 2020 $173.0 M -2.35%
Jan. 1, 2019 $177.2 M 218.72%
Jan. 1, 2018 $55.6 M -16.52%
Jan. 1, 2017 $66.6 M -62.42%
Jan. 1, 2016 $177.2 M -19.13%
Jan. 1, 2015 $219.1 M -11.31%
Jan. 1, 2014 $247.0 M 0.73%
Jan. 1, 2013 $245.2 M 129.17%
Jan. 1, 2012 $107.0 M -85.25%
Jan. 1, 2011 $725.3 M -54.81%
Jan. 1, 2010 $1.61 B 35.00%
Jan. 1, 2009 $1.19 B -37.50%
Jan. 1, 2008 $1.90 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Harrow Health, Inc. Categories

United States languages Healthcare languages Drug Manufacturers—Specialty & Generic
United States Healthcare United States Drug Manufacturers—Specialty & Generic

Stocks & Indices

Harrow Health, Inc. has the following listings and related stock indices.


Stock: NASDAQ: HROW

Stock: FSX: 3IP

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.